Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study
- 7 December 2017
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 53 (2) , 130-133
Abstract
Background: In recent years, success rates of empirical H. pylori therapies have fallen in many countries. Although antibiotic resistance and poor adherence are described as the main factors for treatment failure, in China, iatrogenic factors also play an important role. Objective: To investigate why patients experienced multiple failures, we performed a retrospective, single center study using questionnaires to identify causes of treatment failure other than antibiotic resistance. Methods: This study was conducted from January 2016 to July 2017 in a general hospital. Patients with at least two H. pylori treatment failures who completed the questionnaire were entered. The survey covered characteristics of the study population, regimens used, and adherence to therapy. Results: Two hundred and ninety three patients were included in the final analysis. The top three most antibiotic combinations as the first-line treatment were a PPI plus clarithromycin–metronidazole (24.6%, 72/293), clarithromycin–levofloxacin (23.5%, 69/293) and clarithromycin–amoxicillin (21.5%, 63/293). Clarithromycin-containing regimens were repeatedly used in 178 patients (60.8%) and levofloxacin-containing regimens repeatedly in 88 patients (30.0%). Fifty patients (17.1%) had poor adherence per treatment history and 32 (10.9%) stopped treatment because of nonmedical reasons. Conclusions: In order to increase the success of H. pylori eradication therapy, the effect of prior therapies needs to be given more consideration. Patient education to enhance adherence also needs to be improved.Keywords
Funding Information
- National Natural Science Foundation of China (81370592, 81500504)
This publication has 13 references indexed in Scilit:
- Management of Helicobacter Pylori in the United States: Results from a national survey of gastroenterology physiciansPreventive Medicine, 2017
- Primary Antibiotic Resistance of Helicobacter pylori in ChinaDigestive Diseases and Sciences, 2017
- Real‐world practice and Expectation of Asia‐Pacific physicians and patients in Helicobacter Pylori eradication (REAP‐HP Survey)Helicobacter, 2017
- Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapyThe Korean Journal of Internal Medicine, 2015
- Kyoto global consensus report onHelicobacter pylorigastritisGut, 2015
- Changes in the first line Helicobacter pylori eradication rates using the triple therapy–a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group)Journal of Gastroenterology and Hepatology, 2014
- Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapyBMJ, 2013
- Fourth Chinese National Consensus Report on the management of Helicobacter pylori infectionJournal of Digestive Diseases, 2013
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysisInternational Journal of Epidemiology, 2002